IPO demand must be real: the SFC’s October 2026 circular and what it means for issuers and directors

On 13 October 2026 the Securities and Futures Commission (SFC) told Hong Kong’s IPO gatekeepers that some listings may have been propped up by money the issuer itself provided. On the same day it suspended trading in a household-name tea chain and froze about HK$4.66 billion of assets linked to two alleged IPO-rigging groups. The circular is addressed to sponsors and bookrunners, but almost every red flag in it describes something an issuer, its directors or its controlling shareholders would do.

In brief

• Demand must be real. Any arrangement in which the issuer or its insiders fund subscriptions, guarantee placees a return, or route IPO proceeds back to placees after listing can create a false market.
• The red flags point at the issuer. Five of the SFC’s six red flags concern payments, relationships or instructions coming from the listing applicant, its directors, shareholders or business partners.
• Directors sign the confirmation. The allotment results announcement must confirm there are no undisclosed side arrangements involving the issuer group, its directors, or its controlling, substantial or existing shareholders. Directors need to be able to stand behind it.
• The SFC is acting before harm spreads. Between September and October 2026 it directed trading suspensions in two issuers, froze record sums and paused vetting of 65 applications earlier in the year.
• Fund flows are the evidence trail. Prepayments, notes, fund subscriptions and “wealth management” products around the listing date are being traced to their counterparties and ultimate beneficiaries.

What the circular says

The circular (26EC62) follows up the SFC’s 30 January 2026 circular on sponsor work (26EC4). It credits sponsors with real progress, then turns to the problem the SFC now ranks as serious: “dubious arrangements” that create suspicious orders or artificially inflate demand for IPO shares.

The circular did not arrive alone. On 12 October the SFC published consultation conclusions on amendments to the Securities and Futures (Stock Market Listing) Rules (SMLR). On 13 October it issued restriction notices against two alleged IPO-rigging groups and directed a suspension of dealings in Sichuan Baicha Baidao Industrial (ChaPanda, 02555), a month after doing the same to Cloudbreak Pharma (02592). Sources: Gibson Dunn, Davis Polk, 21st Century Business Herald.

The expectations on intermediaries are direct. Sponsors, overall coordinators (OCs) and capital market intermediaries (CMIs) must assess the red flags individually and together, make further enquiries, record their conclusions and escalate concerns. They must report to the SFC and the Stock Exchange during vetting, not after listing, and reject suspicious orders where concerns remain unresolved. The SFC also said intermediaries involved in problematic IPOs may be prioritised for inspection.

For issuers, that means harder questions. Expect sponsors to review fund flows and material transactions between the last audited balance sheet date and listing, to hold substantive bring-down interviews with controlling shareholders and executive directors, and to ask for back-to-back confirmations.

The framework that applies to issuers, shareholders and directors

None of the obligations below is new. What the circular changes is how hard intermediaries will test them, and how quickly the SFC will act when they fail. Four layers matter to a listing applicant’s board.

Three points deserve emphasis for directors.

1. Funded subscribers are not “the public”. Under rule 8.24, a person whose subscription was financed directly or indirectly by a core connected person, or who habitually takes instructions from one, does not count towards the public float. An issuer-funded order is therefore a float problem as well as a disclosure problem.
2. The Placing Guidelines restrict who can receive shares. Without the Exchange’s prior consent, shares may not be allocated to directors, existing shareholders, their close associates or connected clients of the bookrunners, and placees must be independent of the issuer and its connected persons.
3. Paragraph 21 reaches into the boardroom. OCs and CMIs must establish who investors are and how they relate to the issuer, and they may not accept rebates or preferential arrangements. The issuer has to give them complete and accurate information on investor relationships, and the prospectus discloses the fixed and discretionary fees paid to the syndicate. A board that steers allocations, or introduces investors without disclosing the link, is the source of the problem paragraph 21 is designed to catch.

Directors also carry the usual duties. Rule 3.08 imposes fiduciary duties and duties of skill, care and diligence. Rule 3.09D requires each director to obtain legal advice on the role and confirm they understand it. The prospectus responsibility statement under Appendix D1A is given by the directors collectively and individually. After listing, treasury investments of IPO proceeds can trigger notifiable or connected transaction rules (Chapters 14 and 14A) and inside information disclosure (SFO Part XIVA).

Six red flags, and what each asks of the board

The SFC describes listing applicants that appear to have provided undisclosed subscription money or guaranteed returns to designated investors or their connected parties. In some cases it suspects IPO proceeds were moved out of the newly listed company under undisclosed agreements, labelled as investments in financial products, and secretly channelled back to major placees. The circular lists six non-exhaustive red flags. Only one, unusual orders, is mainly about the order book; the other five start with the issuer.

The return leg, IPO proceeds leaving the company as so-called financial product investments, is what the SFC suspects in its October enforcement action. Each arrow is a point where one of the red flags below can surface.

1. Issuer and insiders → investors. Subscription money, loans, prepayments or a guaranteed return, before listing (red flags 1, 2 and 5).
2. Investors → IPO book. Orders that look like genuine demand, sometimes steered, late or outsized (red flags 3, 4 and 6).
3. IPO book → issuer. IPO proceeds arrive at the newly listed company.
4. Issuer → investors, the return leg. Proceeds leave as “financial product” investments and are channelled back to placees (red flag 1).

The SFC’s message to intermediaries is that a deal should not proceed simply because it can. For a board, the corollary is uncomfortable but simple: if genuine demand is weak, the right answer is a smaller or later offer, not a support arrangement.

The “no side arrangements” confirmation belongs to the directors

The circular expects the allotment results announcement to confirm that, except as disclosed in the listing document, there are no side agreements or arrangements concerning the subscription, purchase, disposal, valuation or turnover of the shares. The confirmation covers the applicant group, its directors, its controlling, substantial and existing shareholders, their close associates and any other party (Gibson Dunn).

Three consequences follow.

• Its reach is wide. It is not limited to the company. Every director and every class of shareholder, and their close associates, falls within it.
• It must be earned. Sponsors will support it with bring-down interviews, fund-flow reviews and back-to-back confirmations from the people it names. Directors should verify the facts before signing, not after.
• A false confirmation is a legal exposure. An inaccurate statement in an announcement can breach rule 2.13 of the Listing Rules and, where it induces dealing, sections 277 and 298 of the SFO.

The ChaPanda case shows why this matters. Its 2024 allotment results announcement already stated that, to the directors’ knowledge, placees’ subscriptions were not financed directly or indirectly by the company, its directors or controlling shareholders (TMTPost). The SFC now says it has serious concerns that the same IPO may have been rigged.

Case studies: ChaPanda, Cloudbreak and Tianju Dihe

The three cases below are live. Everything in them is a suspicion or allegation by the SFC, or a matter reported by the companies or the press. Investigations are continuing, no one has been found to have broken the law, and the SFC has not said that any of the three companies or their management took part in a scheme. We discuss them because they show what the regulator is looking for.

The two groups named by the SFC

On 13 October the SFC issued restriction notices to brokers holding the client accounts of two groups it suspects of fraudulent schemes to create a false appearance of demand for IPO shares (Caproasia, Dimsum Daily).

The brokers are not subjects of the investigation. The SFC said the notices preserve assets so that investors may later be compensated through a restitution process.

ChaPanda (Sichuan Baicha Baidao, 02555)

ChaPanda listed on 23 April 2024 at HK$17.50 a share, raising net proceeds of about HK$2.46 billion with no cornerstone investors. Demand was thin: the Hong Kong public offer was 0.50 times subscribed and the international offer 1.11 times, so roughly 95% of the shares went to the international tranche. Press analysis of the allotment results put the top ten placees at more than 80% of the international shares. The stock fell 26.9% on its first day and last traded at HK$4.035 (TMTPost, Huxiu).

On 13 October 2026 the SFC directed a suspension, citing serious concerns that the IPO may have been rigged to create an artificial impression of demand. The company said it would cooperate fully and that its purchases of wealth management products did not use offering proceeds; about HK$707 million of proceeds remained unused at 30 June 2026 (36Kr, CNR). A shareholders’ meeting on an interim dividend and share incentive plan was shelved, and the stock left the Hang Seng Composite Index from 23 October.

How it fits the framework. Weak genuine demand met by a deal that still closed on schedule maps to red flag 6. High placee concentration with unclear ultimate investors maps to red flag 5 and to rule 8.24. Any proceeds routed back to placees through financial products would engage red flag 1, use-of-proceeds disclosure and section 300 of the SFO. And the allotment announcement’s “not financed by the company or its insiders” statement would, if wrong, raise sections 277 and 298 and rule 2.13.

Cloudbreak Pharma (02592)

Cloudbreak, a US-based clinical-stage ophthalmic drug developer, listed under Chapter 18A on 3 July 2025 at HK$10.10, raising about HK$612 million. It closed its first day 39% down. The Reynold Lemkins Group (Asia) Limited, the entity at the centre of the second group, was among its cornerstone investors with about HK$22 million (SCMP, Caixin, Jiemian).

On listing day the company put about HK$47.1 million of proceeds into a North Rock Fund SPC fund with an expected annual return of 2.53%. It did not announce the investment until 30 March 2026. After discussion with its auditor it reclassified the holding as a financial asset at fair value through profit or loss rather than a cash equivalent, and redeemed about HK$48 million on 22 April 2026 (TMTPost). The SFC has not said whether this investment is connected to its concerns. It directed a suspension on 10 September 2026, when the shares stood at HK$1.19, 88% below the offer price (The Standard), and on 13 October linked the first group to the IPO.

How it fits the framework. An undisclosed investment of proceeds on listing day sits squarely within red flag 1’s “shortly after listing”. Whatever the investigation finds, a nine-month disclosure gap corrected only after auditor input engages rule 2.13, Chapter 14 size testing and inside information obligations. A cornerstone that turns up in another alleged scheme is a red flag 2 question about how investors were introduced and vetted.

Tianju Dihe (Suzhou) Technology (02479)

Tianju Dihe, an API data services provider, is the clearest illustration of a “round trip”. Its largest cornerstone and the company dealt with each other in both directions within days of the listing (21st Century Business Herald, Jiemian, Futu HSTong, NetEase).

Neither note issuer held a banking or financial licence, and neither had repaid or paid anything on the notes when the forensic report was issued. In round numbers, about two-thirds of the cornerstone’s HK$117 million went back to its side of the table within two weeks of listing.

How it fits the framework. Buying a cornerstone’s notes the day after it signed up is red flag 1 in textbook form, and red flag 5 if the cornerstone’s money was effectively the issuer’s. Under rule 8.24 an issuer-financed subscriber is not part of the public. A cornerstone holding a large share of the offer while the international book was undersubscribed points to red flag 6. Placing proceeds with unlicensed note issuers raises questions under rule 3.08 and Chapters 14 and 14A, and the company now faces a long suspension, management turnover and possible delisting.

A practical checklist for directors

The cases share five patterns: demand that was weak or oddly shaped, money moving around the listing date, investors who were also counterparties, confirmations that may not hold, and costs that fell on the company and all its shareholders. The checklist below is built to catch each of them.

Before listing

• List every relationship and transaction between the group, its directors and shareholders, and any prospective cornerstone, placee or their affiliates, and disclose them to the sponsor and OCs.
• Put any prepayment, loan, investment, note or fund subscription in the months either side of listing to the board for approval, with the counterparty and ultimate beneficiary identified.
• Answer bring-down interviews fully, and check the facts before signing back-to-back confirmations.
• Obtain written confirmations from each director and controlling shareholder that they have no side arrangements of the kind the allotment announcement will deny.
• Adopt a treasury policy for IPO proceeds before listing, not after the first auditor query.

During bookbuilding

• Do not promise, fund or arrange anyone’s subscription, directly or through a shareholder or business partner.
• Do not instruct the OCs to allocate shares to particular investors.
• Disclose how any investor you introduced is connected to the group.
• If genuine demand is weak, accept a smaller or later offer.

After listing

• Invest proceeds only as the prospectus describes, after verifying counterparties and ultimate beneficiaries.
• Size-test treasury investments under Chapter 14, check connected status under Chapter 14A, and announce promptly where required.
• Watch for unusual price and volume movements and respond to regulatory enquiries quickly.
• Review treasury controls regularly, and escalate any payment that could benefit an IPO investor.

Important notice

This article is for general information only and is not legal advice. The matters described in the case studies are suspicions or allegations made by the SFC, or facts reported by the companies or the press; investigations are continuing and no person has been found to have contravened any law or rule. Information is current as of 28 October 2026.

Sources

• SFC, Circular to licensed corporations carrying out sponsor work and engaging in bookbuilding and placing activities (26EC62), 13 October 2026
• SFC, SFC takes action against suspected IPO-rigging syndicates and suspends dealings in Baicha shares (26PR168), 13 October 2026
• SFC, SFC suspends dealings in Cloudbreak Pharma Inc. shares over suspected IPO rigging (26PR140), 10 September 2026
• Gibson Dunn, Hong Kong SFC Renews Scrutiny of IPO Sponsors and Bookrunners as Listings Surge
• Davis Polk, Hong Kong SFC recognises sponsor progress but sharpens its focus on IPO misconduct
• Caproasia, Hong Kong SFC Issues Notices for Suspected IPO Rigging and Market Manipulation
• Dimsum Daily, SFC suspends Baicha trading as probe targets suspected IPO-rigging syndicates
• Yicai Global, Hong Kong Regulator Freezes Record USD594 Million of Assets in Suspected IPO Fraud Cases
• The Standard, SFC orders biotech firm Cloudbreak Pharma to suspend trading over suspected IPO rigging
• South China Morning Post, Hong Kong watchdog investigates Cloudbreak Pharma for ‘rigged’ IPO
• Caixin Global, Hong Kong Halts Cloudbreak Pharma Shares Over Suspected ‘Rigged’ IPO
• 21st Century Business Herald, on Tianju Dihe’s cornerstone and notes and on the SFC circular
• TMTPost, on the IPO placing investigation; Jiemian, on Reynold Lemkins and Liu Haoran; Futu HSTong, on Tianju Dihe and Reynold Lemkins; NetEase, on Tianju Dihe’s suspension
• Huxiu, on ChaPanda’s IPO and suspension; 36Kr, on ChaPanda’s use of proceeds; CNR, on ChaPanda’s response
• SFC licence register mirror, Sun Ran (AUZ782)